Okyo Pharma Limited (OKYO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2017 | 03-2017 | 09-2016 | 03-2016 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,572 | 3,925 | 4,487 | 5,129 | 5,973 |
| Receivables | 171 | 154 | 162 | 164 | 238 |
| TOTAL | $3,797 | $4,102 | $4,727 | $5,371 | $6,297 |
| Non-Current Assets | |||||
| PPE Net | 57 | 15,278 | 15,696 | 17,165 | 17,882 |
| Intangibles | 0 | 8,377 | 8,748 | 9,648 | 10,174 |
| TOTAL | $57 | $23,655 | $24,445 | $26,813 | $28,056 |
| Total Assets | $3,854 | $27,757 | $29,172 | $32,184 | $34,353 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 292 | 184 | 223 | 124 | 217 |
| Accrued Expenses | 20 | 37 | N/A | 56 | 5 |
| TOTAL | $316 | $259 | $223 | $181 | $222 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $316 | $259 | $223 | $181 | $222 |
| Shareholders' Equity | |||||
| Common Shares | 88,676 | 82,588 | 0 | 95,124 | 100,308 |
| Retained earnings | -85,124 | -55,340 | -58,803 | -64,712 | -67,992 |
| Other shareholders' equity | -14 | 251 | 1,503 | 1,590 | 1,816 |
| TOTAL | $3,538 | $27,498 | $28,949 | $32,003 | $34,131 |
| Total Liabilities And Equity | $3,854 | $27,757 | $29,172 | $32,184 | $34,353 |